Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men

Exclusion Criteria

• •Have a history of intolerance to Androderm or other testosterone products.
• •Prostate specific antigen (PSA) level ≥ 4.0 ng/mL
• •Prostate cancer or severe benign prostatic hypertrophy (BPH)
• •Have significant abnormalities in the physical examination at screening.
• •Have current dermatological disease, skin damage or blemishes.
• •Have participated in an investigational drug study within 30 days prior to screening.